Sale!

SMAD4 Gene Juvenile Polyposis Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SMAD4 Gene Juvenile Polyposis Syndrome NGS Genetic DNA Test is a comprehensive genetic screening that identifies mutations in the SMAD4 gene associated with Juvenile Polyposis Syndrome (JPS). This hereditary condition significantly increases the risk of developing multiple polyps in the gastrointestinal tract and elevates colorectal cancer susceptibility. Using Next-Generation Sequencing (NGS) technology, this test provides precise detection of pathogenic variants that can guide personalized medical management and cancer prevention strategies. The test is particularly important for individuals with a family history of JPS or early-onset gastrointestinal symptoms. Results typically take 3-4 weeks and require a simple blood sample or extracted DNA. The test costs $500 USD with our current discount, providing affordable access to advanced genetic screening for hereditary cancer risk assessment.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SMAD4 Gene Juvenile Polyposis Syndrome NGS Genetic DNA Test

Comprehensive Genetic Screening for Hereditary Gastrointestinal Cancer Risk

The SMAD4 Gene Juvenile Polyposis Syndrome NGS Genetic DNA Test represents a cutting-edge approach to hereditary cancer risk assessment, specifically targeting mutations associated with Juvenile Polyposis Syndrome (JPS). This sophisticated genetic analysis utilizes Next-Generation Sequencing technology to provide comprehensive screening for individuals at risk of developing this inherited gastrointestinal condition.

What This Advanced Genetic Test Detects

This specialized DNA test specifically identifies pathogenic variants in the SMAD4 gene, which plays a crucial role in the TGF-β signaling pathway responsible for cell growth regulation and tumor suppression. Mutations in this gene disrupt normal cellular processes, leading to the development of multiple juvenile polyps throughout the gastrointestinal tract and significantly increasing cancer susceptibility.

  • Detection of SMAD4 gene mutations associated with Juvenile Polyposis Syndrome
  • Identification of specific pathogenic variants affecting TGF-β signaling
  • Assessment of hereditary cancer risk in gastrointestinal tissues
  • Evaluation of genetic predisposition to colorectal and gastric cancers

Who Should Consider This Genetic Screening

This test is particularly recommended for individuals presenting with specific clinical indicators or family history patterns that suggest increased risk for Juvenile Polyposis Syndrome:

  • Individuals with multiple juvenile polyps in the gastrointestinal tract
  • Patients with a family history of Juvenile Polyposis Syndrome
  • Those experiencing unexplained gastrointestinal bleeding or abdominal pain
  • Individuals with early-onset colorectal cancer diagnoses
  • Patients with combined features of hereditary hemorrhagic telangiectasia and polyposis
  • Family members of individuals with confirmed SMAD4 mutations

Significant Benefits of Genetic Testing

Undergoing SMAD4 genetic testing provides numerous advantages for proactive health management and personalized medical care:

  • Early Risk Identification: Detect genetic predisposition before symptom development
  • Personalized Surveillance: Implement targeted screening protocols based on genetic status
  • Family Planning Guidance: Make informed reproductive decisions with genetic counseling
  • Preventive Interventions: Initiate early polyp removal and cancer prevention strategies
  • Reduced Anxiety: Provide clarity and certainty about hereditary cancer risk
  • Comprehensive Care Planning: Coordinate multidisciplinary medical management

Understanding Your Genetic Test Results

Genetic test interpretation requires professional medical guidance, but understanding the general categories can help patients prepare for discussions with their healthcare providers:

  • Positive Result: Indicates the presence of a pathogenic SMAD4 mutation, confirming increased JPS and cancer risk, necessitating enhanced surveillance and preventive measures
  • Negative Result: No detected mutation in the SMAD4 gene, though continued monitoring may be recommended based on family history and clinical presentation
  • Variant of Uncertain Significance: Identifies a genetic change with unclear clinical implications, requiring ongoing research and periodic re-evaluation
  • No Mutation Detected: In individuals with strong clinical evidence of JPS, additional genetic testing may be recommended

Test Pricing and Availability

Test Component Price (USD)
SMAD4 Gene Juvenile Polyposis Syndrome NGS Genetic DNA Test – Discount Price $500
SMAD4 Gene Juvenile Polyposis Syndrome NGS Genetic DNA Test – Regular Price $700

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States, ensuring convenient access to advanced genetic screening in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and all principal urban centers. Our network of certified genetic counselors and medical professionals provides seamless coordination for patients seeking hereditary cancer risk assessment.

Pre-Test Preparation Requirements

To ensure optimal testing accuracy and comprehensive risk assessment, the following preparations are essential:

  • Complete clinical history documentation of the patient undergoing testing
  • Genetic counseling session to construct detailed family pedigree charts
  • Identification of family members affected by Juvenile Polyposis Syndrome
  • Review of personal and family medical history for gastrointestinal conditions
  • Discussion of testing implications, benefits, and potential outcomes

Sample Collection and Processing

Our testing process accommodates multiple sample types for patient convenience:

  • Blood Sample: Standard venous blood draw performed by certified phlebotomists
  • Extracted DNA: Previously isolated DNA samples from qualified laboratories
  • FTA Card Blood Spot: Convenient single-drop blood collection on specialized filter paper

Test results are typically available within 3 to 4 weeks from sample receipt, with expedited options available for urgent clinical situations.

Take Control of Your Genetic Health Today

Proactive genetic screening represents a powerful tool in modern preventive medicine. By identifying SMAD4 gene mutations early, individuals can implement targeted surveillance strategies, reduce cancer risk through timely interventions, and make informed healthcare decisions for themselves and their families.

Schedule your comprehensive genetic assessment today by calling our dedicated genetic counseling team at +1(267) 388-9828 or book your appointment online through our secure patient portal. Take the first step toward personalized cancer prevention and family health management.